NCT00541320 - Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) | Biotech Hunter

Timeline

Start Date

February 28, 2007

Conditions

Venous Thromboembolism

Interventions

DRUG

GW813893

Trial Locations (8)

GSK Clinical Trials Call Center, Charleston

GSK Clinical Trials Call Center, Decatur

GSK Clinical Trials Call Center, St. Petersburg

GSK Clinical Trials Call Center, Birmingham

GSK Clinical Trials Call Center, San Antonio

GSK Clinical Trials Call Center', Phoenix

GSK Clinical Trials Call Center, Phoenix

GSK Clinical Trials Call Center, Yuba City